Core Scientific annual return on equity
2021
2022
Core Scientific Return on Equity (ROE) Growth & History (CORZ)
Core Scientific's return on equity was −460.65% for fiscal 2022.
View full Core Scientific company overviewCore Scientific annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −460.65% | −467.71 pp |
| 2021 | 2021-12-31 | 7.06% | — |
Core Scientific quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2022 | 2022-09-30 | −177.66% | −175.25 pp |
| Q2 2022 | 2022-06-30 | −105.04% | −101.50 pp |
| Q1 2022 | 2022-03-31 | −37.78% | −51.88 pp |
| Q4 2021 | 2021-12-31 | 4.60% | — |
| Q3 2021 | 2021-09-30 | −2.40% | — |
| Q2 2021 | 2021-06-30 | −3.54% | — |
| Q1 2021 | 2021-03-31 | 14.10% | — |
Core Scientific return on equity trends
Between the periods ended 2021-12-31 and 2022-12-31, Core Scientific's return on equity decreased from 7.06% to −460.65%, a change of −467.71 percentage points. The latest reported quarter, Q3 2022, shows −177.66%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Scientific source filings ↗